Skip to main content
Premium Trial:

Request an Annual Quote

Finnish Red Cross to Use GeneGo's Software for Blood, Transplant Studies

NEW YORK (GenomeWeb News) —The Finnish Red Cross has licensed GeneGo’s bioinformatics software for use in clinical and research projects it plans to conduct on blood taken from transfusion patients, GeneGo said today.
 
The FRC Blood Service will use the MetaCore and MetaDrug bioinformatics and chemoinformatics suites for blood group and cell type analysis from blood transfusions as well as for tissue typing of donors involved in organ, bone marrow, cord blood, and bone marrow stem cell replacement transplants.
 
The MetaCore 5.0 is used to help target, validate, and identify biomarkers for disease states and toxicology, and the MetaDrug 5.0 is used to predict toxicity, metabolism, and the effects of novel small molecules.
 
Financial terms of the agreement were not released.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.